.jpg?format=webp&width=780)
Superior laryngeal nerve (SLN) blocks have proven effective in treating chronic cough, according to a study comparing them to placebo injections. The research involved outpatient participants with neurogenic cough, and those receiving SLN blocks reported significant improvement compared to the placebo group. Symptoms were measured using the Leicester Cough Questionnaire (LCQ) and a patient symptom log. The treatment group showed increased LCQ scores, particularly in the social domain, while the placebo group saw no significant change. No major side effects were reported, indicating that SLN blocks are safe and beneficial for neurogenic cough treatment. Further research is needed to optimize protocols and monitor long-term outcomes.
Like
Save
Share